Companies / Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc

Nasdaq: LGNDCIK 886163SAN DIEGO, CA

Financials · FY2025

Revenue$268.09M
Net income$124.45M
Total debt$1.13B
Cash$1.01B
Diluted EPS$6.13
Shares outstanding19.9M

Ownership

19.9M shares outstanding · as of Aug 4, 2026
2.3%Insiders
Ownership
Insiders2.32%462,224
Institutions105.18%20,968,458
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Davis Todd CCEOChief Executive Officer · Director
1.00%199,381
Aryeh JasonDirector
0.51%102,580
Kozarich John WDirector
0.21%42,622
Reardon AndrewCLO & Secretary
0.18%36,869
Sabba Stephen LDirector
0.16%32,793
Lamattina John LDirector
0.14%26,969
Espinoza OctavioChief Financial Officer
0.11%21,010

Institutional holders 362

View all →
HolderValue% of shares
BlackRock, Inc.$980.19M15.56%
Vanguard Group Inc$392.11M10.40%
State Street Corporation$261.25M4.15%
Janus Henderson Group PLC$201.62M5.07%
Nomura Asset Management International Inc.$121.78M3.23%
Geode Capital Management, LLC$111.61M2.80%
Fmr LLC$109.50M2.91%
Chicago Capital, LLC$106.15M2.82%
Stephens Investment Management Group LLC$98.76M2.48%
Invesco Ltd.$97.65M2.59%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 14, 2026Davis Todd C
CEO
OtherCommon Stock$2.87M-16K
-7.30%
197,985
0.99% of shares
low
Feb 14, 2026Davis Todd C
CEO
OtherCommon Stock$1.50M-8K
-4.49%
173,941
0.87% of shares
low
Jun 11, 2026Aryeh Jason
Director
SellCommon Stock$1.13M-5K
-4.20%
102,580
0.51% of shares
medium
Jun 10, 2026Lamattina John L
Director
SellCommon Stock$856.8K-3K
-11.21%
26,969
0.14% of shares
medium
Feb 14, 2026Espinoza Octavio
Executive
OtherCommon Stock$824.1K-4K
-10.93%
36,531
0.18% of shares
low
Feb 15, 2026Davis Todd C
CEO
OtherCommon Stock$782.2K-4K
-2.17%
191,691
0.96% of shares
low
Feb 14, 2026Reardon Andrew
Executive
OtherCommon Stock$750.6K-4K
-9.42%
39,255
0.20% of shares
low
Mar 4, 2026Espinoza Octavio
Executive
SellCommon Stock$712.6K-3K
-13.61%
21,662
0.11% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LGND——53220K504—